Ledger.Open graph →
SEC Form D · Amendment · filed October 24, 2024

FlightPath Biosciences, Inc

Offering
$9.0M
Sold
$8.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Birmingham, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Jeffrey M. Sloan · Birmingham, MIExec · DirectorCurtis Scribner · Birmingham, MIDirectorMatthew Tindall · Birmingham, MIExec · DirectorCristina Larkin · Birmingham, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗